If you took Yaz birth control pills and developed a blood clot or other severe side effect, contact Schmidt & Clark, LLP regarding a Yaz lawsuit. Bayer HealthCare, the manufacturer of Yaz, has already paid $1.4 billion to settle 7,000 lawsuits involving Yaz and Yasmin, for an average settlement of $200,000 per plaintiff.
Yaz Lawsuit Settlements
Yaz lawsuits have been centralized in a federal Multi-District Litigation (MDL), which is like a class action lawsuit. The litigation includes over 11,000 lawsuits and nearly 14,000 plaintiffs who were injured by Yaz, Yasmin, and other birth control pills manufactured by Bayer HealthCare that contain drospirenone.
Yaz lawsuits are centralized here:
- U.S. District Court for the Southern District of Illinois, In re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation
As of October 2013, approximately 7,000 lawsuits involving venous blood clot injuries (pulmonary embolism, deep vein thrombosis, etc.) have settled for approximately $1.4 billion. It is possible that arterial blood clot injuries (heart attack, stroke, etc.) could settle in the near future.
Although terms of each settlement were not disclosed, the average payment was approximately $200,000, with significantly higher payments likely for plaintiffs who were severely injured, disabled, or lost a loved one. An additional $24 million has been set aside to settle lawsuits involving gallstones and gallbladder disease.
What is the problem with Yaz?
Yaz is a birth control pill that prevents pregnancy with a combination of estrogen (ethinyl estradiol) and the “fourth-generation” progestin (drospirenone). The problem with Yaz is that studies have linked it to as much as a tripled increased risk of blood clots compared to birth control pills that contain older progestins, such as levonorgestrel.
Yaz Warning Letters for Misleading, Off-Label Marketing
When the FDA approved Yaz in March 2006, they indicated it for the prevention of pregnancy, treatment of moderate acne, and Pre-Menstrual Dysphoric Disorder (PMDD). Soon after, Bayer launched a $200 million advertising campaign that promoted Yaz to treat everything from headaches to anxiety.
As a result, millions of women were misled into believing Yaz was superior to other birth control pills, which doubled sales to $616 million by 2008. That same year, the FDA faulted Bayer for illegally promoting Yaz for “off-label” uses. Although doctors are allowed to prescribe drugs for uses that were never approved or evaluated by the FDA, pharmaceutical companies are prohibited from “off-label” marketing, and they must provide complete risk information.
According to the FDA, Bayer’s balloon ads for Yaz were “misleading because they broaden the drug’s indication, overstate the efficacy of Yaz, and minimize serious risks associated with the use of the drug.” Unfortunately, problems persisted into 2009, when the FDA issued another warning letter for online Yaz ads that “fail to communicate any risk information.”
Yaz Side Effects
- Blood clots
- Venous thromboembolism
- Heart attack
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Gallbladder disease
- Organ damage (blindness, brain damage, etc.)
- And more